| #131 |
Halong Vu |
Monsanto Technology |
1 |
| #131 |
Karl K. Berggren |
MIT |
1 |
| #131 |
Oliver P. Peoples |
Metabolix |
1 |
| #131 |
Timothy J. Hazen |
Microsoft |
1 |
| #131 |
Andrew Wilson |
Raindance Technologies |
1 |
| #131 |
Lukasz Zielinski |
Schlumberger Technology |
1 |
| #131 |
Alexander Douglas Perkins |
Boston Dynamics |
1 |
| #131 |
Alexander Kirby Tee |
C.R. Bard |
1 |
| #131 |
Brian Cali |
Ironwood Pharmaceuticals |
1 |
| #131 |
Kendra Marchant |
Emc Ip Holding Company |
1 |
| #131 |
Samuel Shian |
Harvard University |
1 |
| #131 |
Matthew Hodges |
Geopri |
1 |
| #131 |
David G. Winkler |
Ucb Pharma S.A. |
1 |
| #131 |
Simon G. Stone |
Giner |
1 |
| #131 |
Edward T. Kopesky |
Cambridge Polymer Group |
1 |
| #131 |
David Lee Rostocil, Jr. |
IBM |
1 |
| #131 |
Darby Schmidt |
Syros Pharmaceuticals |
1 |
| #131 |
Roman Tunkel |
Becton, Dickinson And |
1 |
| #131 |
Elisha Gallaudet |
Amazon |
1 |
| #131 |
Reeves Hoppe Briggs |
Microsoft |
1 |
| #131 |
Eunice Sun Park |
Eisai R&D Management Co. |
1 |
| #131 |
David Rodger |
Spotify Ab |
1 |
| #131 |
Dennis W. Connelly |
Tepha |
1 |
| #131 |
Christopher F. Thompson |
Merck |
1 |
| #131 |
Neal W. Spellmeyer |
MIT |
1 |
| #131 |
Eduard Luss-Lusis |
Vertex Pharmaceuticals Incorporated |
1 |
| #131 |
Robert Mulligan |
Arsenal Medical |
1 |
| #131 |
Jeffrey H. Alexander |
Oracle |
1 |
| #131 |
Alexander Kordun |
IBM |
1 |
| #131 |
Dan J. Burns |
Mitsubishi Electric |
1 |
| #131 |
Robert Kuszewski |
Microsoft |
1 |
| #131 |
Whitney Terese Young |
Cerapedics |
1 |
| #131 |
Manuel A. Balderas |
Akamai Technologies |
1 |
| #131 |
Natalia Y. Mazaeva |
Medtronic |
1 |
| #131 |
Andrew Kleppner |
Emc |
1 |
| #131 |
Bruce Bishop |
Veolia Water Technologies |
1 |
| #131 |
Chandran V. Seshagiri |
— |
1 |
| #131 |
Shahan Nercessian |
Trustees Of Tufts College |
1 |
| #131 |
Paul D. Lynch |
Cubist Pharmaceuticals |
1 |
| #131 |
Lewis D. Pennington |
Amgen |
1 |
| #131 |
Zachary Robinson |
Novartis Ag |
1 |
| #131 |
Todd Hinck |
Intel |
1 |
| #131 |
Juhan Sonin |
Infobionic |
1 |
| #131 |
Bryan S. Robinson |
MIT |
1 |
| #131 |
Wender Wang |
Thermacell Repellents |
1 |
| #131 |
Paul Bay |
Ab Initio Technology |
1 |
| #131 |
Vasiliki Demas |
T2 Biosystems |
1 |
| #131 |
Liping Yang |
Merck |
1 |
| #131 |
Shawn S. Kuo |
Analog Devices |
1 |
| #131 |
Karen E. Thomas-Alyea |
A123 Systems |
1 |